These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9423304)

  • 21. [Structural characteristics of osteopontin for calcium oxalate crystal].
    Umekawa T
    Nihon Hinyokika Gakkai Zasshi; 1999 Mar; 90(3):436-44. PubMed ID: 10349302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uric acid, monosodium urate and ammonium urate urinary relative saturations in normo-uricuric calcium oxalate stone formers.
    Labeeuw M; Gerbaulet C; Pozet N; Zech P; Divry P; Traeger J
    Eur Urol; 1980; 6(4):241-6. PubMed ID: 7389778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of fibronectin content in urinary macromolecules between normal subjects and recurrent stone formers.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto K; Takahara S; Okuyama A
    Eur Urol; 2001 Oct; 40(4):458-62. PubMed ID: 11713403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers.
    Médétognon-Benissan J; Tardivel S; Hennequin C; Daudon M; Drüeke T; Lacour B
    Urol Res; 1999; 27(1):69-75. PubMed ID: 10092156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.
    Shum DK; Gohel MD
    Clin Sci (Lond); 1993 Jul; 85(1):33-9. PubMed ID: 8149691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocyte Mitochondrial Function in Calcium Oxalate Stone Formers.
    Williams J; Holmes RP; Assimos DG; Mitchell T
    Urology; 2016 Jul; 93():224.e1-6. PubMed ID: 26972146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystallization kinetics of calcium oxalate in fresh, minimally diluted urine: comparison of recurrent stone formers and healthy controls in a continuous mixed suspension mixed product removal crystallizer.
    Kavanagh JP; Nishio S; Garside J; Blacklock NJ
    J Urol; 1993 Mar; 149(3):614-7. PubMed ID: 8437278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced inhibitory activity of uronic-acid-rich protein in urine of stone formers.
    Atmani F; Lacour B; Jungers P; Drüeke T; Daudon M
    Urol Res; 1994; 22(4):257-60. PubMed ID: 7871640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibitory activity of urinary macromolecule upon calcium oxalate crystal aggregation using an aggregometer].
    Ebisuno S; Miyata K; Kohjimoto Y; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1993 Feb; 84(2):339-44. PubMed ID: 8464186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal growth of calcium oxalate in urine of stone-formers and normal controls.
    Achilles W; Dekanić D; Burk M; Schalk C; Tucak A; Karner I
    Urol Res; 1991; 19(3):159-64. PubMed ID: 1887523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examination of crystalluria in freshly voided urines of recurrent calcium stone formers and normal individuals using a new filter technique.
    Fan J; Chandhoke PS
    J Urol; 1999 May; 161(5):1685-8. PubMed ID: 10210440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome and the risk of calcium stones.
    Sakhaee K; Capolongo G; Maalouf NM; Pasch A; Moe OW; Poindexter J; Adams-Huet B
    Nephrol Dial Transplant; 2012 Aug; 27(8):3201-9. PubMed ID: 22247230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
    J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nidus, crystalluria and aggregation: key ingredients for stone enlargement.
    Saw NK; Rao PN; Kavanagh JP
    Urol Res; 2008 Feb; 36(1):11-5. PubMed ID: 18030459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between body mass index, lipid profiles, and types of urinary stones.
    Inci M; Demirtas A; Sarli B; Akinsal E; Baydilli N
    Ren Fail; 2012; 34(9):1140-3. PubMed ID: 22889148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.